Bank of New York Mellon
IMGN

Bank of New York Mellon’s Immunogen Inc IMGN Stock Holding History

Bank of New York Mellon’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,063,500
Closed -$31.5M – 4378
2023
Q4 		$31.5M Sell
1,063,500
-732,610
-41% -$14.6M 0.01% 1346
2023
Q3 		$28.5M Buy
1,796,110
+703,117
+64% +$11.7M 0.01% 1342
2023
Q2 		$20.6M Buy
1,092,993
+310,960
+40% +$3.67M ﹤0.01% 1538
2023
Q1 		$3M Sell
782,033
-7,273
-0.9% -$31K ﹤0.01% 2576
2022
Q4 		$3.91M Sell
789,306
-26,766
-3% -$145K ﹤0.01% 2475
2022
Q3 		$3.9M Buy
816,072
+69,210
+9% +$365K ﹤0.01% 2427
2022
Q2 		$3.36M Sell
746,862
-52,040
-7% -$226K ﹤0.01% 2537
2022
Q1 		$3.8M Buy
798,902
+52,243
+7% +$289K ﹤0.01% 2564
2021
Q4 		$5.54M Sell
746,659
-9,825
-1% -$61.1K ﹤0.01% 2409
2021
Q3 		$4.29M Buy
756,484
+71,175
+10% +$411K ﹤0.01% 2573
2021
Q2 		$4.52M Sell
685,309
-124,490
-15% -$868K ﹤0.01% 2547
2021
Q1 		$6.56M Sell
809,799
-15,928
-2% -$130K ﹤0.01% 2318
2020
Q4 		$5.33M Buy
825,727
+42,644
+5% +$249K ﹤0.01% 2329
2020
Q3 		$2.82M Sell
783,083
-2,323
-0.3% -$9.38K ﹤0.01% 2485
2020
Q2 		$3.61M Buy
785,406
+6,824
+0.9% +$29K ﹤0.01% 2365
2020
Q1 		$2.65M Buy
778,582
+54,154
+7% +$237K ﹤0.01% 2406
2019
Q4 		$3.7M Buy
724,428
+29,663
+4% +$101K ﹤0.01% 2492
2019
Q3 		$1.68M Sell
694,765
-22,946
-3% -$60.9K ﹤0.01% 2847
2019
Q2 		$1.56M Buy
717,711
+95,576
+15% +$226K ﹤0.01% 2951
2019
Q1 		$1.69M Buy
622,135
+16,713
+3% +$72.4K ﹤0.01% 2867
2018
Q4 		$2.91M Sell
605,422
-9,073
-1% -$55.1K ﹤0.01% 2555
2018
Q3 		$5.82M Buy
614,495
+68,407
+13% +$658K ﹤0.01% 2334
2018
Q2 		$5.31M Sell
546,088
-44,602
-8% -$470K ﹤0.01% 2359
2018
Q1 		$6.21M Buy
590,690
+106,522
+22% +$1.05M ﹤0.01% 2231
2017
Q4 		$3.1M Sell
484,168
-64,318
-12% -$397K ﹤0.01% 2592
2017
Q3 		$4.2M Sell
548,486
-29,354
-5% -$195K ﹤0.01% 2423
2017
Q2 		$4.11M Buy
577,840
+138,923
+32% +$636K ﹤0.01% 2420
2017
Q1 		$1.7M Buy
438,917
+58,516
+15% +$171K ﹤0.01% 2946
2016
Q4 		$776K Buy
380,401
+13,569
+4% +$27.2K ﹤0.01% 3400
2016
Q3 		$983K Sell
366,832
-35,584
-9% -$103K ﹤0.01% 3189
2016
Q2 		$1.24M Sell
402,416
-64,741
-14% -$406K ﹤0.01% 3010
2016
Q1 		$3.98M Sell
467,157
-3,962
-0.8% -$33.5K ﹤0.01% 2294
2015
Q4 		$6.39M Buy
471,119
+2,829
+0.6% +$34.8K ﹤0.01% 2084
2015
Q3 		$4.5M Sell
468,290
-72,560
-13% -$1.06M ﹤0.01% 2296
2015
Q2 		$7.78M Buy
540,850
+10,188
+2% +$112K ﹤0.01% 2092
2015
Q1 		$4.75M Buy
530,662
+56,772
+12% +$411K ﹤0.01% 2342
2014
Q4 		$2.89M Buy
473,890
+22,393
+5% +$205K ﹤0.01% 2619
2014
Q3 		$4.78M Buy
451,497
+27,753
+7% +$314K ﹤0.01% 2345
2014
Q2 		$5.02M Sell
423,744
-12,027
-3% -$151K ﹤0.01% 2323
2014
Q1 		$6.51M Sell
435,771
-210
-0% -$3.31K ﹤0.01% 2172
2013
Q4 		$6.4M Buy
435,981
+1,353
+0.3% +$20.8K ﹤0.01% 2149
2013
Q3 		$7.4M Buy
434,628
+12,573
+3% +$221K ﹤0.01% 1993
2013
Q2 		$7M Buy
+422,055
New +$6.84M ﹤0.01% 1996

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bank of New York Mellon's IMGN Position: Q1 2024 in Review

Bank of New York Mellon sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,063,500 shares — an estimated $31.5M sold.

Bank of New York Mellon first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $31.5M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Bank of New York Mellon reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 1,063,500 Immunogen Inc shares in Q1 2024, an estimated $31.5M.
  • Bank of New York Mellon first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • Bank of New York Mellon's Immunogen Inc position peaked at $31.5M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Bank of New York Mellon's 13F filing for Q1 2024, filed 25 Apr 2024.